The Usefulness of Biosynthetic Vascular Graft Omniflow II and Autologous Veins for the Treatment of Massive Infection of Dacron Vascular Graft with Enterococcus faecalis HLAR


Share / Export Citation / Email / Print / Text size:

Polish Journal of Microbiology

Polish Society of Microbiologists

Subject: Microbiology


ISSN: 1733-1331
eISSN: 2544-4646





Volume / Issue / page

Related articles

VOLUME 65 , ISSUE 4 (December 2016) > List of articles

The Usefulness of Biosynthetic Vascular Graft Omniflow II and Autologous Veins for the Treatment of Massive Infection of Dacron Vascular Graft with Enterococcus faecalis HLAR

Witold Woźniak * / Robert Bajno / Michał Świder / Piotr Ciostek

Keywords : Enterococcus faecalis, abdominal aortic surgery, Omniflow II, vascular graft infection, vascular prosthesis

Citation Information : Polish Journal of Microbiology. Volume 65, Issue 4, Pages 471-474, DOI:

License : (CC BY-NC-ND 4.0)

Received Date : 12-July-2016 / Accepted: 13-September-2016 / Published Online: 28-December-2016



Infections of vascular grafts are the most severe complications in vascular surgery. We present the case of a 73-year-old male with infection of a dacron prosthesis with a strain of Enterococcus faecalis. The patient was treated with replacement of a full prosthesis with a combined graft constructed from Biosynthetic Vascular graft Omniflow and autologous veins. This graft is recommended for implantation in patients with a higher risk of infection. Our case is one of the first reported usage of this kind of graft in the aortic region and in a 2 years observa­tion period no recurrence of infection was observed.

Content not available PDF Share



Bandyk D.F., T.M. Bergamini, E.V. Kinney, G.R. Seabrook and J.B. Towne. 1991. In situ replacement of vascular prostheses infected by bacterial biofilms. J. Vasc. Surg. 13: 575–583.


Batt M., E. Jean-Baptiste, S. O’Connor, P.J. Bouillanne, P. Haudebourg, R. Hassen-Khodja, S. Declemy and R. Farhad. 2008. In situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur. J. Vasc. Endovasc. Surg. 362: 182–188.


Bronk M. and A. Samet. 2008. Hospital enterococcal bacteremias. Post. Mikrobiol. 47: 339–344.


Budtz-Lilly J., N. Eldrup, S. Vammen and J. Laustsen. 2014. Femoral vein repair of arterial infections: technical tips to reduce procedure time. Vasc. Endovascular Surg. 48: 367–371.


Dirven M., M.F. van der Jagt, W.B. Barendregt and D. van der Vliet. 2015. The efficacy of autologous femoropopliteal vein reconstruction for primary aortic and aortic graft infection. Ann. Vasc. Surg. 29: 1188–1195.


Dünschede F., J. Stabrauskaite, G. Weisser, C. Espinola-Klein,B. Dorweiler and C.F. Vahl. 2015. Crural bypass for critical lower limb ischemia with Omniflow II prosthesis. Thorac. Cardiovasc. Surg. 64: 311–315.


Fellmer P.T., G. Wiltberger, H.M. Tautenhahn, I. Matia, F. Krenzien and S. Jonas. 2014. Early results after peripheral vascular replacement with biosynthetic collagen prosthesis in cases of graft infection (in German). Zentralbl Chir. 139: 546–551.


Krasznai A.G., M. Snoeijs, M.P. Siroen, T. Sigterman, A. Korsten, F.L. Moll and L.H. Bouwman. 2015. Treatment of aortic graft infection by in situ reconstruction with Omniflow II biosynthetic prosthesis. Vascular. DOI: 10.1177/1708538115621195.


Lew W. and W. Moore. 2011. Antibiotic-impregnated grafts for aortic reconstruction. Semin. Vasc. Surg. 244: 211–219.


Neufang A., B. Dorweiler, C. Espinola-Klein, S. Savvidis, M. Doem-land, S. Schotten and C.F. Vahl. 2014. Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts. J. Vasc. Surg. 60: 1543–1553.


Palumbo R., P. Niscola, S. Calabria, S. Fierimonte, M. Bevilacqua, L. Scaramucci, B. Tolu, P. de Fabritiis and F. Bondanini. 2009. Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron. Clin. Pract. 1132: 76–80.


Pupka A., B. Dolińska-Krajewska, S. Pawłowski and P. Szyber. 2004. Immunosuppression in the transplantation of the fresh arterial homograft – case report. Adv. Clin. Exp. Med. 13: 371–374.


Samson R.H., F.J. Veith, G.S. Janko, S.K. Gupta and L.A. Scher. 1988. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J. Vasc. Surg. 8: 147–53.


Seabroock G.R. 1990. Pathobiology of graft infections. Sem. Vasc. Surg. 3: 81–88.


Swain T.W., K.D. Calligaro and M.D. Dougherty. 2004. Management of infected aortic prosthetic grafts. Vasc. Endovascular Surg. 38: 75–82.


Töpel I., T. Betz, C. Uhl, M. Wiesner, S. Bröckner and M. Steinbauer. 2012. Use of biosynthetic prosthesis (Omniflow II) to replace infected infrainguinal prosthetic grafts – first results. Vasa. 413: 215–220.


Verhelst R., V. Lacroix and H. Vraux. 2000. Use of cryopreserved arterial homografts for mamagement of infected prosthetic grafts: a multicentric study. Ann. Vasc. Surg. 14: 602–607.


Werkmeister J.A., J.F. White, G.A. Edwards and J.A. Ramshaw. 1995. Early performance appraisal of the Omniflow II vascular prosthesis as an indicator of long-term function. J. Long Term. Eff. Med. Implants. 5: 1–10.


Wiltberger G., I. Matia, M. Schmelzle, F. Krenzien, H.M. Hau, B. Freitas, S. Jonas and P.T. Fellmer. 2014. Mid-and long-term results after replacement of infected peripheral vascular prosthetic grafts with biosynthetic collagen prosthesis. J. Cardiovasc. Surg. 55: 693–698.